Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | PGR | P06401 | 3/20 | 0.42 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.42 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.39 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21917368 | 0.81 | KDM4E (0.55) | KDM4EATML3MBTL1PGRMAPK8 | |
| SCHEMBL21140960 | 0.79 | KDM4E (0.53) | KDM4EATML3MBTL1PGRMAPK8 | |
| SCHEMBL24622863 | 0.78 | KDM4E (0.52) | KDM4EATML3MBTL1PGRMAPK8 | |
| SCHEMBL21776068 | 0.78 | KDM4E (0.52) | KDM4EATML3MBTL1PGRMAPK8 | |
| SCHEMBL19652294 | 0.78 | CYP19A1 (0.53) | KDM4ECYP19A1CYP1A2CYP2C19P2RX4 | |
| SCHEMBL17245465 | 0.76 | L3MBTL1 (0.75) | KDM4EATML3MBTL1PGRMAPK8 | |
| SCHEMBL21388936 | 0.75 | L3MBTL1 (0.82) | KDM4EATML3MBTL1PGRMAPK8 | |
| SCHEMBL6569217 | 0.75 | L3MBTL1 (0.74) | KDM4EATML3MBTL1PGRMAPK8 | |
| SCHEMBL14492832 | 0.75 | CYP19A1 (0.59) | KDM4ECYP19A1CYP1A2CYP2C19P2RX4 | |
| SCHEMBL31962 | 0.75 | L3MBTL1 (1.00) | KDM4EATML3MBTL1CYP19A1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11706972-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-18 | — | — | US | disclosed |
| US-20170069857-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2017-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11706972-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OSBP | KDM4E 3789/4885ATM 2712/4885L3MBTL1 2045/4885 |
| US-20170069857-A1 | Organic Electroluminescent Materials and Devices | OCIAD2, OCIAD1, OSBP | KDM4E 3789/4885ATM 2712/4885L3MBTL1 2045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.